Collectively, our findings show that aTim-3 mAbs act on Tim-3+ APCs in a PS-dependent fashion to disrupt the trogocytosis of activated TA-specific CD8+ T cells and PD-1+Tim-3+ CD8+ TILs in MM. The gene discussed is HAVCR2; the disease is Miyoshi myopathy.